Questions arise over drug firms' lobbying

Published: 2002-07-29 07:00:00

Updated: 2002-07-29 07:00:00

Market observers say that the whole domestic pharmaceutical industry are drawn into the vortex of the illegal lobbying of multinational pharmaceutical firms, amidst the government reservation of a set of drug pricing policies to discourage the use of high-priced drugs, such as reference pricing s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK